Author Archives: yun

Infection

Olfactory dysfunction following mild SARS-CoV-2 infection associated with neurological changes in structural connectivity

Posted on by yun
14
Aug

In a recent article published in Scientific Reports, researchers investigated the changes in olfactory bulb volume and structural connectivity of the brain in patients with olfactory dysfunction (OD) following mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Study: Altered structural connectivity in olfactory disfunction after mild COVID-19 using probabilistic tractography. Image Credit: Design_Cells/Shutterstock.com Background Globally, […]

Continue reading →
Infection

The protective effect of previous infections and vaccinations on SARS-CoV-2 Omicron infection

Posted on by yun
14
Aug

Hybrid immunity has been acquired by significant percentage of the population through previous infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) vaccination. A new Nature Communications study estimates the protective effect of hybrid immunity on infection with the SARS-CoV-2 Omicron variant in a prospective community-based cohort study conducted in the […]

Continue reading →
Infection

Report details man’s leg discoloration after COVID-19 infection

Posted on by yun

A new scientific paper highlights a little-known symptom of long COVID: blue legs. Called acrocyanosis, it happened to a 33-year-old man cared for by Dr. Manoj Sivan at the University of Leeds in the United Kingdom. Advertisement The patient stood and just one minute later, his legs began to redden, becoming increasingly more blue with […]

Continue reading →
Cancer and neoplasms

In a Securities and Exchange Commission (SEC) filing last Friday, US oncology focused biotech Syros Pharmaceuticals (Nasdaq: SYRS) disclosed it has received notice from Incyte Corp (Nasdaq: INCY) that it was opting out of a blood cancer treatment collaboration dated January 2018, on novel therapies for myeloproliferative neoplasms. Syros’ shares closed up 1.6% at $3.82 following the announcement, which comes just a couple of weeks after US pharma…

Posted on by yun

In a Securities and Exchange Commission (SEC) filing last Friday, US oncology focused biotech Syros Pharmaceuticals (Nasdaq: SYRS) disclosed it has received notice from Incyte Corp (Nasdaq: INCY) that it was opting out of a blood cancer treatment collaboration dated January 2018, on novel therapies for myeloproliferative neoplasms. Syros’ shares closed up 1.6% at $3.82 […]

Continue reading →
Cardiovascular

Wake up! Oversleeping on weekends could affect your heart’s health

Posted on by yun
14
Aug

If we believe that we can make up for a lack of sleep during the week by indulging in a weekend slumber, you’re solely mistaken. A recent study by Penn State scientists, published in the journal Psychosomatic Medicine, unearthed a startling revelation – depriving ourselves of adequate sleep, with a mere five hours per night, […]

Continue reading →
Blood

Common cold virus linked to potentially fatal blood clotting disorder: Study

Posted on by yun
14
Aug

PTI | | Posted by Parmita Uniyal, New Delhi Aug 14, 2023 07:14 PM IST Share Via Copy Link The common respiratory virus, which causes mild cold-and flu-like symptoms, may be associated with blood clots and severe thrombocytopenia. The common respiratory virus, which causes mild cold-and flu-like symptoms, may be associated with blood clots and […]

Continue reading →